Position in CELC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$29,170,880
+$13,968,461 QoQ
Shares Held
278,827
+109.3% QoQ
Ownership
0.570%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#43
of 274 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,414,542,351 across 195 Biotechnology names. CELC ranks #22 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,505 | $40,844,986 |
All Filings in CELC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,170,880 | 278,827 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $15,202,419 | 133,191 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $10,471,302 | 104,986 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,145,096 | 43,423 | Shares | Defined | 2025-10-09 | |
| No filing history on record for this holder in this stock. | ||||||